Although the principle of gene therapy may be straightforward, the complexity and scope of the analytical methods associated with this technology are not.
Gene therapy introduces a number of analytical challenges that are not encountered with conventional biopharmaceutical products. Complex and time-consuming bioassays are needed throughout the study to assess product potency, confirm product identity, identify impurities and test for immunogenicity.
Svar is in a unique position to offer assistance in any gene therapy project. We have robust platforms suited for all phases of drug development, as well as the experience and knowledge from our diagnostic and bioanalytical services. We are currently developing cell-based assays for immunogenicity and potency testing.
By listening to your requirements, we can propose a solution specifically for your needs. Contact us today to speak to one of our scientific experts and find out how our cell-based solutions can help with your Gene Therapy projects in 2020.